Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007;29(1):103-5.
doi: 10.1080/08860220601039528.

A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient

Rahmi Yilmaz  1 , Hadim Akoglu, Alper Kirkpantur, Saadettin Kilickap, Mustafa Arici, Bulent Altun, Tuncay Aki, Yunus Erdem, Unal Yasavul, Cetin Turgan
Affiliations
Free article
Case Reports

A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient

Rahmi Yilmaz et al. Ren Fail. 2007.
Free article

Abstract

Renal transplant recipients are susceptible to Kaposi's sarcoma (KS) because of treatment with immunosuppressive drugs. Sirolimus, a new immunosuppressive agent, has been successfully used for immune-suppression in kidney transplant recipients. Several studies have shown the potential role of sirolimus to inhibit progression of KS in kidney-transplant recipients. This report details a kidney-transplant recipient with cutaneous KS who had a complete remission in response to sirolimus therapy.

PubMed Disclaimer

Publication types

LinkOut - more resources